Masimo (NSDQ:MASI) announced earlier this week that it launched a new patient monitoring and connectivity hub.
The first application of Dual SET Oximetry for Root offers a significant advancement to the company’s Masimo SET-guided critical congenital heart disease (CCHD) screening, according to a news release. Masimo will combine the platform with the CE-marked Masimo SET MOC-9 module and the Eve CCHD newborn screening application for Root to enhance the automation of newborn screenings using Dual SET Oximetry.
Get the full story at our sister site, Medical Design & Outsourcing.